The somatic <i>POLE</i> P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy

Abstract excerpt

// Sung-Min Ahn 1, 2, * , Adnan Ahmad Ansari 3, 4, * , Jihun Kim 4, 5 , Deokhoon Kim 4 , Sung-Min Chun 4, 5 , Jiyun Kim 5 , Tae Won Kim 6 , Inja Park 7 , Chang-Sik Yu 7 , Se Jin Jang 4, 5 1 Division of Hematology-Oncology, Department of Internal Medicine, Gachon University Gil Hospital, Incheon, South Korea 2 Gachon Institute of Genome Medicine and Science, Gachon University Gil Hospital, Incheon, South Korea 3...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Immunotherapy and Biomarkers
• Share to Colorectal Cancer Treatments and Studies
• Share to Genetic factors in colorectal cancer